Gilead Sciences Announces Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Gilead Sciences (GILD) Tops Q3 EPS by 21c, Offers Guidance
October 25, 2018 4:06 PM EDTGilead Sciences (NASDAQ: GILD) reported Q3 EPS of $1.84, $0.21 better than the analyst estimate of $1.63. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.38 billion.
GUIDANCE:
Gilead Sciences sees Q4 2018 revenue of $20.8-21.3 billion, versus the consensus of... More
